NA
Nikhil Aggarwal
About Nikhil Aggarwal
Data last updated:
Nikhil Aggarwal is a Director at Efpia Medicine Private Limited (since 2024), Director at Ernst Pharmacia Private Limited (since 2024) and Director at Fawn Incor Private Limited (since 2024), and holds 3 more current directorships. The companies operate in Pharma and FMCG. The largest current company by reported revenue is Efpia Medicine Private Limited at ₹3.08 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Efpia Medicine Private Limited U47721HR2024PTC121120 | Director | 28 Apr 2024 | 2024 | ₹3.08 Cr (FY 2025) | Active |
| Ernst Pharmacia Private Limited U47721HR2024PTC121691 | Director | 20 May 2024 | 2024 | Active | |
| Fawn Incor Private Limited U47721HR2024PTC121625 | Director | 16 May 2024 | 2024 | Active | |
| Wonne International Private Limited U47721HR2024PTC121268 | Director | 03 May 2024 | 2024 | Active | |
| Akasa Essentials Private Limited U47722HR2024PTC120071 | Director | 22 Mar 2024 | 2024 | Active | |
| Akasa Organics Private Limited U46499HR2023PTC116661 | Director | 21 Nov 2023 | 2023 | Active |
Board colleagues of Nikhil Aggarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kritika Parnami | 10609380 | Efpia Medicine Private Limited , Wonne International Private Limited | Director |
| Neha Dharmesh Bangdiwala | 10399479 | Ernst Pharmacia Private Limited , Fawn Incor Private Limited and 2 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nikhil Aggarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nikhil Aggarwal
Nikhil Aggarwal currently holds 6 directorships: Efpia Medicine Private Limited (Director, since 28 Apr 2024, revenue ₹3.08 Cr (FY 2025)); Ernst Pharmacia Private Limited (Director, since 20 May 2024); Fawn Incor Private Limited (Director, since 16 May 2024); Wonne International Private Limited (Director, since 03 May 2024); Akasa Essentials Private Limited (Director, since 22 Mar 2024); and 1 more.
Nikhil Aggarwal was first appointed on 21 Nov 2023 as Director at Akasa Organics Private Limited. The most recent appointment on record is 20 May 2024 at Ernst Pharmacia Private Limited.
The current boards of Nikhil Aggarwal's companies include Kritika Parnami (Efpia Medicine Private Limited), Neha Dharmesh Bangdiwala (Ernst Pharmacia Private Limited).